Chief Executive Officer
With over three decades of experience in the pharmaceutical industry, Ms. Dixon is a seasoned leader adept at fostering collaboration across diverse stakeholders in healthcare. Her expertise spans team leadership, strategic planning, scientific data analysis, biomarker evaluation, and regulatory submissions for drugs and devices. Notably, she has contributed to the development of 15 marketed compounds across various clinical domains, including pain management, reproductive health, and mental health disorders like schizophrenia and Alzheimer’s.
As the CEO and Founder of Innovenn, Inc. in Madison, WI, Ms. Dixon spearheads the creation and execution of high-impact business strategies. She excels in aligning short-term objectives with long-term goals, motivating teams, and ensuring operational alignment with the company’s mission. By forging strategic partnerships and driving innovation, Innovenn is positioned as a leader in healthcare innovation, dedicated to addressing unmet patient needs and enhancing healthcare delivery.
Additionally, as the owner of Improvita, Inc., Ms. Dixon drives forward-thinking solutions in human factors testing for medical devices, pharmaceuticals, and healthcare software. Leveraging a passion for innovation, Improvita specializes in rigorous human factors engineering assessments and usability testing to ensure product effectiveness and regulatory compliance. Through consultancy services, the company guides clients through regulatory processes, ultimately improving patient outcomes and user satisfaction.
Mary E. Dixon’s leadership is instrumental in driving success and positively impacting healthcare innovation and patient care.
